Crinetics Pharmaceuticals, Inc. (CRNX)
84.79
+0.10
(+0.12%)
USD |
NASDAQ |
Aug 24, 16:00
84.79
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Debt to Equity Ratio : 0.0396 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0396 |
| March 31, 2026 | 0.0374 |
| December 31, 2025 | 0.0489 |
| September 30, 2025 | 0.0458 |
| June 30, 2025 | 0.0426 |
| March 31, 2025 | 0.0405 |
| December 31, 2024 | 0.039 |
| September 30, 2024 | 0.0631 |
| June 30, 2024 | 0.0642 |
| March 31, 2024 | 0.06 |
| December 31, 2023 | 0.096 |
| September 30, 2023 | 0.0952 |
| June 30, 2023 | 0.0101 |
| March 31, 2023 | 0.0101 |
| December 31, 2022 | 0.0097 |
| September 30, 2022 | 0.0095 |
| June 30, 2022 | 0.0092 |
| March 31, 2022 | 0.0125 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.0121 |
| September 30, 2021 | 0.0219 |
| June 30, 2021 | 0.0221 |
| March 31, 2021 | 0.0311 |
| December 31, 2020 | 0.0287 |
| September 30, 2020 | 0.0269 |
| June 30, 2020 | 0.0258 |
| March 31, 2020 | 0.0498 |
| December 31, 2019 | 0.0476 |
| September 30, 2019 | 0.0443 |
| June 30, 2019 | 0.0415 |
| March 31, 2019 | 0.0398 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Vertex Pharmaceuticals, Inc. | 0.0977 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
| Pfizer Inc. | 0.7418 |
| Bristol Myers Squibb Co. | 2.019 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.322B |
| Total Liabilities (Quarterly) | 129.92M |
| Shareholders Equity (Quarterly) | 1.192B |
| Current Ratio | 15.57 |
| Net Debt Paydown Yield | 0.02% |